Skip to content

Advertisement

Open Peer Review Reports for: Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
17 Oct 2016 Submitted Original manuscript
3 Nov 2016 Reviewed Reviewer Report - Marwan Sabbagh
22 Nov 2016 Author responded Author comments - Abdelrahman Abushouk
Resubmission - Version 2
22 Nov 2016 Submitted Manuscript version 2
15 Jan 2017 Reviewed Reviewer Report - JOSHUA D. GRILL
7 Feb 2017 Author responded Author comments - Abdelrahman Abushouk
Resubmission - Version 3
7 Feb 2017 Submitted Manuscript version 3
15 Mar 2017 Reviewed Reviewer Report - JOSHUA D. GRILL
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Mar 2017 Editorially accepted
4 Apr 2017 Article published 10.1186/s12883-017-0850-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement